Skip to main content
. 2019;20(10):2995–3000. doi: 10.31557/APJCP.2019.20.10.2995

Figure 3.

Figure 3

Kaplan-Meier Log Rank Analysis Showed that Patients in the “Steep” Group (SMI Inclination < -0.01) had Poorer OS, Measured from the Start of Second-Line GD Chemotherapy, Compared with Those in the “Gentle” Group (5.4 versus 10.7 months, log-rank p-value < 0.01)